Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted July 16, 2024
Infla-650 Herbal Dietary Supplement Recalled
On July 16, 2024, Guru Inc. issued a recall of one lot of Infla-650 Herbal Dietary Capsules because they were found to contain acetaminophen, diclofenac, and phenylbutazone.
(See ConsumerLab's Joint Health Supplements Review for tests of products promoted for joint pain.)
The recall follows an FDA warning to consumers in June 2024 not to buy or use the capsules after FDA testing found them to contain the undeclared drugs.
Acetaminophen is an over-the-counter (OTC) pain reliever that can cause a rare, but potentially fatal skin reaction, and, in large doses, liver damage.
Diclofenac is a prescription non-steroidal anti-inflammatory drug (NSAID) that can cause serious cardiovascular events such as heart attack or stroke, as well as bleeding, ulceration, and fatal tears of the stomach and intestines, or liver toxicity. Phenylbutazone is an NSAID that was discontinued for human use in the United States due to the risk of serious and life-threatening injuries, including bone marrow toxicity. People with anemia, a low white or red blood cell count, or decreased blood platelets may be at a greater risk of death or serious injury.
Recalled Infla-650 capsules (see product photos) are labeled as containing ashwagandha, fenugreek seed, shilajit, and other herbs, and were promoted for pain relief. They were distributed nationwide through online sales and in retail stores. The recalled capsules are packaged in stand-up pouches of 60 capsules with a green and white color label that can be further identified by the following:
People who have purchased the recalled affected product should not use it and return it to the place of purchase. Those who have experienced any problems due to the use of this product are advised to contact their healthcare provider.
For more information, use the link below.
GURU INC. Issues Voluntary Nationwide Recall of Infla-650 Herbal Dietary Supplement Capsules Due to Hidden Drug Ingredients
See related recalls and warnings
FDA Warns Consumers Not to Use Infla-650 Due to Undeclared Drugs
FDA Warns Consumers Not to Use Tapee Tea
Toxic Herb Found In Weight Supplements
FDA Warns Consumers of Supplement Containing Prescription Anti-Inflammatory Drug
FDA Warns Consumers Not to Use Ossos-Sans Supplement for Joints
Drug Found in Umary Supplement
(See ConsumerLab's Joint Health Supplements Review for tests of products promoted for joint pain.)
The recall follows an FDA warning to consumers in June 2024 not to buy or use the capsules after FDA testing found them to contain the undeclared drugs.
Acetaminophen is an over-the-counter (OTC) pain reliever that can cause a rare, but potentially fatal skin reaction, and, in large doses, liver damage.
Diclofenac is a prescription non-steroidal anti-inflammatory drug (NSAID) that can cause serious cardiovascular events such as heart attack or stroke, as well as bleeding, ulceration, and fatal tears of the stomach and intestines, or liver toxicity. Phenylbutazone is an NSAID that was discontinued for human use in the United States due to the risk of serious and life-threatening injuries, including bone marrow toxicity. People with anemia, a low white or red blood cell count, or decreased blood platelets may be at a greater risk of death or serious injury.
Recalled Infla-650 capsules (see product photos) are labeled as containing ashwagandha, fenugreek seed, shilajit, and other herbs, and were promoted for pain relief. They were distributed nationwide through online sales and in retail stores. The recalled capsules are packaged in stand-up pouches of 60 capsules with a green and white color label that can be further identified by the following:
- Product name: Infla-650 Herbal Dietary Supplement
- Lot number: In-032
- Expiration date: NOV. 2027
People who have purchased the recalled affected product should not use it and return it to the place of purchase. Those who have experienced any problems due to the use of this product are advised to contact their healthcare provider.
For more information, use the link below.
GURU INC. Issues Voluntary Nationwide Recall of Infla-650 Herbal Dietary Supplement Capsules Due to Hidden Drug Ingredients
See related recalls and warnings
FDA Warns Consumers Not to Use Infla-650 Due to Undeclared Drugs
FDA Warns Consumers Not to Use Tapee Tea
Toxic Herb Found In Weight Supplements
FDA Warns Consumers of Supplement Containing Prescription Anti-Inflammatory Drug
FDA Warns Consumers Not to Use Ossos-Sans Supplement for Joints
Drug Found in Umary Supplement